`
`Action Items from NY Meeting fig 22“, 2993
`
`Ltem
`
`0—943!
`
`Elm m
`
`I
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`I
`
`I
`
`12
`
`13
`
`I4
`
`IS
`
`I6
`
`Wrile up draft of Phase ”Phase II
`{ADMEfl'ott} and send to MR I'or edlls
`
`Contract for Euro ODD
`
`5 gm Drug Substance to Giossen
`
`RR
`
`MR
`
`RR
`
`30'II Oct 2003
`
`30'“ 0c12003
`
`[5" Nov 200.1
`
`Sign contract with OpIiNeb
`
`(25ka
`
`15" Nov 2003
`
`File Paton! If possible for TRIUMPH
`(Use Juanita)
`
`MR
`
`15" Dec 2003
`
`lRBt'EIhictt Protocol Submission
`
`WSI’LRIIIO
`
`I3" Dec 2003
`
`Resumes ofpolcnlinl Project loaders to he
`collected for review
`
`EMEA ODD flilng
`
`Sun inhalation toxicology programme
`
`Proposals from CRO:
`
`MR
`
`MR
`
`CS
`
`CS
`
`I5" Dec 2003
`
`IS'I Dec 2003
`
`12'“ Jan 2004
`
`12‘” Jan 2004
`
`Brief Phase II Centers (ucztmuwcw
`Vanderhlt'tfl’apttrm’th/Gleu'on/Partxffltdngm
`Harrow-or}
`
`wsrLR
`
`Is" Fol: 2004
`
`Phase II centres meeting in New York
`
`MR
`
`7‘“ Mar 2004
`
`Prepare Phase II Protocol
`
`WSJ'I-IOIIR
`
`I5” Mar 2004
`
`Animal PK and Repeat Dose
`Remodeling Work
`(Urine mwholitca}
`INDt’CTX Regulatory filings
`
`WS
`
`15" May 200-!
`
`Lunng
`
`30‘“ Jun 2004
`
`Slam Phase II Trial
`
`LRIWSJHO
`
`30"I Sep 2004
`
`LungR. ExecCrnlo meeting, NY. 22'“ Oct 2003
`
`WATSON LABORATORIES V. UNITED THERAPEUTICS, IPR2017-01622
`
`UNITED THERAPEUTICS, EX. 2102
`
`Page 1 of 1
`
`